BMI: the cashflow

MyFinsight

For the year ending 2025-12-31, BMI had -$69,289K decrease in cash & cash equivalents over the period. $169,672K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-12-31
Net earnings	141,634
Depreciation	11,103
Amortization	23,481
Deferred income taxes	-854
Noncurrent employee benefits	136
Stock-based compensation expense	9,190
Receivables	20,115
Inventories	987
Payables	14,399
Prepaid expenses and other assets	3,804
Other liabilities	9,515
Total adjustments	42,064
Net cash provided by operations	183,698
Property, plant and equipment expenditures	14,026
Acquisitions, net of cash acquired	184,024
Net cash used for investing activities	-198,050
Dividends paid	43,529
Proceeds from exercise of stock options	554
Repurchase of common stock for treasury stock	15,002
Net cash used for financing activities	-57,977
Effect of foreign exchange rates on cash	3,040
(decrease) increase in cash and cash equivalents	-69,289
Cash and cash equivalents at beginning of period	295,305
Cash and cash equivalents at end of period	226,016

Unit: Thousand (K) dollars